AVEO PHARMACEUTICALS INC Uncategorized Contracts & Agreements
24 Contracts & Agreements
- Offer Letter by the Registrant to Jebediah Ledell, dated November 12, 2021 (Filed With SEC on March 14, 2022)
- Offer Letter by the Registrant to Michael Ferraresso, dated April 8, 2021 (Filed With SEC on March 14, 2022)
- Offer Letter by and between the Registrant and Erick Lucera, dated December 12, 2019 (Filed With SEC on March 16, 2020)
- Description of Registered Securities (Filed With SEC on March 16, 2020)
- Agreement, dated December 18, 2018, by and between the Registrant and Novartis International Pharmaceutical Ltd (Filed With SEC on March 14, 2019)
- Offer Letter by and between the Registrant and Karuna Rubin dated June 16, 2015 (Filed With SEC on March 14, 2019)
- Offer Letter by and between the Registrant and Nikhil Mehta, dated November 10, 2017 (Filed With SEC on March 13, 2018)
- EXHIBIT A INVENTION AND NON-DISCLOSURE AGREEMENT (Filed With SEC on May 17, 2017)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on November 4, 2016)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions (Filed With SEC on March 15, 2016)
- Page 1 of 2 (Filed With SEC on March 15, 2016)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on November 9, 2015)
- Page 1 of 2 (Filed With SEC on May 7, 2015)
- Confidential Materials omitted and filed separately withthe Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on March 6, 2015)
- [AVEO PHARMACEUTICALS LETTERHEAD] (Filed With SEC on May 7, 2014)
- Confidential Materials omitted and filed separately withthe Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on May 7, 2014)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on May 7, 2014)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. (Filed With SEC on March 13, 2014)
- [AVEO PHARMACEUTICALS LETTERHEAD] (Filed With SEC on March 13, 2014)
- [AVEO PHARMACEUTICALS LETTERHEAD] (Filed With SEC on March 13, 2014)
- Confidential Materials omitted and filedseparately with the Securities and Exchange Commission. Asterisks denote omissions. (Filed With SEC on March 9, 2010)
- Confidential Materials omitted and filedseparately with the Securities and Exchange Commission. Asterisks denote omissions. (Filed With SEC on December 16, 2009)
- Confidential Materials omitted and filedseparately with the Securities and Exchange Commission. Asterisks denote omissions. (Filed With SEC on December 16, 2009)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions. (Filed With SEC on December 16, 2009)
